Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 20 studies | 64% ± 23% | |
deuterosomal cell | 3 studies | 30% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 26% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 60.33 | 241 / 245 | 93% | 2.65 | 465 / 502 |
brain | 100% | 153.11 | 2640 / 2642 | 87% | 4.47 | 611 / 705 |
kidney | 99% | 88.60 | 88 / 89 | 85% | 3.58 | 765 / 901 |
thymus | 99% | 71.84 | 646 / 653 | 78% | 2.21 | 473 / 605 |
breast | 88% | 60.19 | 406 / 459 | 80% | 4.75 | 897 / 1118 |
adrenal gland | 97% | 49.61 | 251 / 258 | 41% | 0.99 | 95 / 230 |
ovary | 88% | 29.57 | 158 / 180 | 45% | 1.44 | 195 / 430 |
lung | 84% | 153.47 | 487 / 578 | 38% | 1.86 | 438 / 1155 |
uterus | 82% | 50.45 | 140 / 170 | 26% | 0.92 | 118 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.70 | 1 / 1 |
bladder | 67% | 18.86 | 14 / 21 | 20% | 0.44 | 103 / 504 |
skin | 76% | 28.10 | 1374 / 1809 | 8% | 0.18 | 39 / 472 |
pancreas | 44% | 9.15 | 144 / 328 | 39% | 0.94 | 70 / 178 |
adipose | 72% | 19.78 | 866 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 60% | 14.12 | 873 / 1445 | 8% | 0.15 | 14 / 183 |
intestine | 53% | 13.17 | 515 / 966 | 4% | 0.05 | 19 / 527 |
eye | 0% | 0 | 0 / 0 | 45% | 1.06 | 36 / 80 |
stomach | 43% | 10.78 | 154 / 359 | 2% | 0.02 | 5 / 286 |
blood vessel | 35% | 6.98 | 463 / 1335 | 0% | 0 | 0 / 0 |
liver | 19% | 3.65 | 42 / 226 | 11% | 0.24 | 46 / 406 |
spleen | 29% | 6.05 | 71 / 241 | 0% | 0 | 0 / 0 |
heart | 22% | 4.31 | 191 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.10 | 4 / 45 |
muscle | 5% | 1.44 | 37 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 1.10 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007018 | Biological process | microtubule-based movement |
GO_0097542 | Cellular component | ciliary tip |
GO_0005813 | Cellular component | centrosome |
GO_0005929 | Cellular component | cilium |
GO_0005868 | Cellular component | cytoplasmic dynein complex |
GO_0005874 | Cellular component | microtubule |
GO_0005737 | Cellular component | cytoplasm |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0003777 | Molecular function | microtubule motor activity |
Gene name | DYNLRB2 |
Protein name | Dynein light chain roadblock-type 2 Dynein light chain roadblock DYNLRB2 protein (Dynein light chain roadblock-type 2) Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2) |
Synonyms | DNLC2B DNCL2B hCG_16745 ROBLD2 |
Description | FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. . |
Accessions | Q7Z4M1 H3BNG9 H3BPA0 ENST00000562982.5 ENST00000561880.1 ENST00000338542.9 ENST00000568035.5 A0A140VJH9 H3BQI1 Q8TF09 ENST00000305904.11 |